IMNM ▲ +1.2% - Immunome, Inc.
$IMNM Immunome to Present Initial First-in-Human Clinical Data for IM-1021 in Advanced B-Cell Lymphomas at ASH 2026
04-NOV-2026 09:02 AM ET
Share this post
More filings for $IMNM
IMNM - Immunome, Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 30, 2026IMNM - Immunome, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $IMNM filing history →💬 Comments
Loading comments…
Leave a comment